Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abishek Vaidya

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Immunity|July 14, 2026
CD4<sup>+</sup> T cells persist with their EomesAbishek Vaidya, Alice O Kamphorst
Science Translational Medicine|November 9, 2022
Advancing beyond the twists and turns of T cell exhaustion in cancerVerena van der Heide, Etienne Humblin, Abishek Vaidya, et al.
Cancer Immunology Research|August 20, 2017
CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T CellsMireya Paulina Velasquez, Arpad Szoor, Abishek Vaidya, et al.
Frontiers in Immunology|May 26, 2022
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX ModelsHong Mu-Mosley, Lauren Ostermann, Muharrem Muftuoglu, et al.
Molecular Therapy Oncolytics|September 1, 2017
T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCCArpad Szoor, Abishek Vaidya, Mireya Paulina Velasquez, et al.
Haematologica|July 28, 2022
Improving the anti-acute myeloid leukemia activity of CD123-specific engager T cells by MyD88 and CD40 costimulationAbishek Vaidya, Erin Doherty, Xiya Wu, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2020
The Art and Science of Selecting a CD123-Specific Chimeric Antigen Receptor for Clinical TestingJanice M Riberdy, Sheng Zhou, Fei Zheng, et al.
Nature Communications|February 1, 2022
CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cellsNikhil Hebbar, Rebecca Epperly, Abishek Vaidya, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
ICOS limits memory-like properties and function of exhausted PD-1 <sup>+</sup> CD8 T cellsEtienne Humblin, Isabel Korpas, Nataliya Prokhnevska, et al.
Immunity|June 26, 2025
Prolonged but finite antigen presentation promotes reversible defects of "helpless" memory CD8<sup>+</sup> T cellsVerena van der Heide, Gabriel Laghlali, Bennett Davenport, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Immunity|July 14, 2026
CD4<sup>+</sup> T cells persist with their EomesAbishek Vaidya, Alice O Kamphorst
Science Translational Medicine|November 9, 2022
Advancing beyond the twists and turns of T cell exhaustion in cancerVerena van der Heide, Etienne Humblin, Abishek Vaidya, et al.
Cancer Immunology Research|August 20, 2017
CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T CellsMireya Paulina Velasquez, Arpad Szoor, Abishek Vaidya, et al.
Frontiers in Immunology|May 26, 2022
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX ModelsHong Mu-Mosley, Lauren Ostermann, Muharrem Muftuoglu, et al.
Molecular Therapy Oncolytics|September 1, 2017
T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCCArpad Szoor, Abishek Vaidya, Mireya Paulina Velasquez, et al.
Haematologica|July 28, 2022
Improving the anti-acute myeloid leukemia activity of CD123-specific engager T cells by MyD88 and CD40 costimulationAbishek Vaidya, Erin Doherty, Xiya Wu, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2020
The Art and Science of Selecting a CD123-Specific Chimeric Antigen Receptor for Clinical TestingJanice M Riberdy, Sheng Zhou, Fei Zheng, et al.
Nature Communications|February 1, 2022
CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cellsNikhil Hebbar, Rebecca Epperly, Abishek Vaidya, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
ICOS limits memory-like properties and function of exhausted PD-1 <sup>+</sup> CD8 T cellsEtienne Humblin, Isabel Korpas, Nataliya Prokhnevska, et al.
Immunity|June 26, 2025
Prolonged but finite antigen presentation promotes reversible defects of "helpless" memory CD8<sup>+</sup> T cellsVerena van der Heide, Gabriel Laghlali, Bennett Davenport, et al.
Pageof 2